Adam T Hill
- British Thoracic Society national bronchiectasis audit 2010 and 2011Adam T Hill
Department of Respiratory Medicine, Royal Infirmary of Edinburgh, 51 Little France Crescent, Edinburgh EH16 4SA, UK
Thorax 67:928-30. 2012..The national audits highlight that the majority of guideline recommendations were not currently being adhered to and demonstrate the need for national quality standards, which are currently in preparation...
- Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasisAdam T Hill
Department of Respiratory Medicine, Royal Infirmary and University of Edinburgh, Scotland, UK
Prim Care Respir J 20:135-40. 2011..Management in primary care is aimed at improving morbidity, and includes; patient education, treatment and monitoring, as well as appropriate referral to secondary care including assessment for long term antibiotics...
- A randomized controlled trial of nebulized gentamicin in non-cystic fibrosis bronchiectasisMaeve P Murray
Department of Respiratory Medicine, Royal Inﬁrmary of Edinburgh, Edinburgh, UK
Am J Respir Crit Care Med 183:491-9. 2011..Bronchiectasis is a chronic debilitating disease with few evidence-based long-term treatments...
- National BTS bronchiectasis audit 2012: is the quality standard being adhered to in adult secondary care?Adam T Hill
Department of Respiratory Medicine, Royal Infirmary of Edinburgh, Edinburgh, UK
Thorax 69:292-4. 2014..The audit highlighted the variable adoption of the quality standard. It will allow the host institutions to benchmark against UK figures and drive quality improvement programmes to promote the quality standard and improve patient care. ..
- Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasisJames D Chalmers
Royal Infirmary of Edinburgh, Department of Respiratory Medicine, Edinburgh, United Kingdom
Am J Respir Crit Care Med 186:657-65. 2012..There are little data to support this hypothesis in patients with non-cystic fibrosis (CF) bronchiectasis...
- Evaluating success of therapy for bronchiectasis: what end points to use?Maeve P Smith
Department of Respiratory Medicine, Royal Infirmary of Edinburgh, UK
Clin Chest Med 33:329-49. 2012..This article explores the utility of potential end points in evaluating therapies used in the long-term management of stable bronchiectasis...
- Do processing time and storage of sputum influence quantitative bacteriology in bronchiectasis?Maeve P Murray
Department of Respiratory Medicine, Royal Infirmary of Edinburgh, Edinburgh EH16 4SA, UK
J Med Microbiol 59:829-33. 2010..1-8.6) c.f.u. ml(-1), P=0.009, and 8.4 (8.1-8.5) c.f.u. ml(-1), P=0.03, respectively]. Bacterial density was not affected by storage for up to 6 h following expectoration at 25 degrees C; beyond this, storage at 4 degrees C is preferred...